Similar to our study, Liang et al. found that ablation of TGF-β signaling by a TGF-β receptor 1 inhibitor, LY364947, inhibited cancer cell proliferation, cancer stem cell population and EMT, and suppressed cancer progression in an orthotopic bladder cancer mouse model23. The gene discussed is TGFB1; the disease is urinary bladder cancer.